Trial registration number
|
RBR-8r9hy8f |
Full text link
Last imported at : Jan. 30, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
http://ensaiosclinicos.gov.br/rg/RBR-8r9hy8f
|
First author
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Carlos Sverdloff
|
Contact
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
carsver@atcgen.com.br
|
Registration date
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2021-01-06
|
Recruitment status
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Not recruiting
|
Study design
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
RCT
|
Allocation
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Randomized
|
Design
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Parallel
|
Masking
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Open label
|
Center
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
single-center
|
Study aim
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Patients hospitalized with COVID-19 who do not require immediate mechanical ventilation (points 3-5 on the ordinal scale). Age from 18 to 80 years. Able to understand the nature and purpose of the study, including risks and adverse effects and with the intention of cooperating with the researcher and acting in accordance with the requirements of the entire trial, which is confirmed by signing the Term Informed Consent Form, prior to any study procedure. Women of childbearing potential should use a safe and effective method of contraception throughout the study. If the participant chooses to abstain from sex or practice any type of relationship that does not pose a risk of pregnancy, the use of contraception is not mandatory.
|
Exclusion criteria
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
The participant is known to be hypersensitive to the studied drug (heparin) or to chemically related compounds. History of serious adverse reactions or hypersensitivity to any drug. The participant has any condition that prevents him from participating in the study due to the investigator's judgment. A participant shows a positive result for beta-HCG test and/or urine test for pregnancy, delivery or abortion in the 12 weeks prior to the scheduled vaccine administration date. Present COPD.
|
Number of arms
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
2
|
Funding
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Galeno Desenvolvimento de Pesquisas ClĂnicas Ltda
|
Inclusion age min
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
18
|
Inclusion age max
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
80
|
Countries
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Brazil
|
Type of patients
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
0
|
primary outcome
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
The mortality rate in each arm of the study will be evaluated and compared;The time to hospital discharge (in days) in each arm of the study will be evaluated and compared
|
Notes
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
|
Phase
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
Phase 2
|
Arms
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)
|
[{"arm_notes": "", "treatment_id": 873, "treatment_name": "Nebulised unfractionated heparin (ufh)", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|